BNP Paribas Asset Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.42M Buy
72,383
+71,802
+12,358% +$3.69M ﹤0.01% 992
2026
Q1
$34.4K Buy
581
+77
+15% +$5K ﹤0.01% 1867
2025
Q4
$31K Buy
504
+120
+31% +$7.34K ﹤0.01% 1813
2025
Q3
$24K Sell
384
-48
-11% -$3.34K ﹤0.01% 1314
2025
Q2
$34K Buy
+432
New +$36.1K ﹤0.01% 1285

Other funds holding PBH

BNP Paribas Asset Management's PBH Position: Q2 2026 in Review

BNP Paribas Asset Management increased its Prestige Consumer Healthcare (PBH) stake by 12,358% in Q2 2026, buying an estimated $3.69M and bringing the position to 72,383 shares worth $3.42M. The position accounts for ﹤0.01% of the portfolio, ranked #992.

BNP Paribas Asset Management first reported a position in PBH in Q2 2025 and has held it in 5 quarters since. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • BNP Paribas Asset Management held 72,383 shares of Prestige Consumer Healthcare worth $3.42M as of Q2 2026.
  • BNP Paribas Asset Management bought 71,802 Prestige Consumer Healthcare shares in Q2 2026, an estimated $3.69M.
  • Prestige Consumer Healthcare made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #992 holding.
  • BNP Paribas Asset Management first reported a position in Prestige Consumer Healthcare in Q2 2025 and has held it in 5 quarters since.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.